Dare Bioscience Inc (DARE)

[willlbone]

Vote on R/S.

[glenn1919]

DARE.................................................https://stockcharts.com/h-sc/ui?s=DARE&p=W&b=5&g=0&id=p86431144783

[starkd748]

It's dead lol

[Monksdream]

DARE new 52 week low

[Monksdream]

DARE new 52 week low

[Monksdream]

DARE new 52 week low

[Monksdream]

DARE newb52 week low

[harry crumb]

Might be a runner in due time

[nonsequetor]

The DARE train has not even left the station... gathering up steam...

[harry crumb]

1.00 average, 100k

[nonsequetor]

I hope everyone loaded up Monday...

[nonsequetor]

Monday, Jan 23, is the day...

[harry crumb]

Yep agree

[nonsequetor]

If Ovaprene is approved by the FDA, it could be the first monthly non-hormonal contraceptive product for women and a first-in-category option for women seeking a hormone-free, self-administered and monthly birth control method.

https://www.biospace.com/article/releases/dare-bioscience-announces-ide-approval-for-a-single-arm-open-label-pivotal-contraceptive-efficacy-study-of-ovaprene-an-investigational-hormone-free-monthly-intravaginal-contraceptive/

[nonsequetor]

DARE starts revenue soon with its first approved drug, Xaciato and its licensing partner OGN. Q1 or Q2. Milestone payments and double digit royalties.

Additionally, they have up to three products entering Ph3 trials this year: Ovaprene, Sildenafil and HRT-1. Ovaprene for sure is entering Ph3 this summer with NIH and licensing partner $BAYRY.

By 2024, they could have FDA-approved products and $4-$5B market share and exclusivity.

[nonsequetor]

DARE Since Post:
$0.3266
(38.27%)
Then:$0.8534
Now:$1.18

Nice chunk of change so far...

[harry crumb]

Mayb, mayb not

[nonsequetor]

Since my call
Jan 03, 2023 9:29 AM

$DARE It has begun...

DARE Since Post:
$0.2566
(30.07%)
Then:$0.8534
Now:$1.11

UM...AH... looks like a winner already...
and it has not even started!

BUT...

I really don't care what negativity others post. I have done my DD, bought low, and will ride the wave to prosperity.

DARE is the real thing, with one of a kind, first in class products, that will turn many heads and make some (who do their own DD) wealthy.

Good fortune to all (except shorts, who bet wrong on this leg up).

[harry crumb]

Could be but highly unlikely this becomes a winner

[nonsequetor]

Just a little bit of DD will prove you wrong.

[harry crumb]

Dont count on it, this team is not an has not proven anything yet. Could use new management for a change, the stock does note promote a very good company

[nonsequetor]

Hop aboard, this is just the beginning!

[nonsequetor]

DARE up over 30% already this year.

[nonsequetor]

Up 20% in 2 days

[nonsequetor]

UP 10% since yesterday morning.

[harry crumb]

This pos needs to be shutdown, what a scam

[harry crumb]

Some more news on dare

[nonsequetor]

Daré Bioscience Announces Subject Screening for Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder Complete

https://finance.yahoo.com/news/dar-bioscience-announces-subject-screening-120000980.html

[harry crumb]

Some news an this turd is stagnant, very boring company here

[harry crumb]

Looks like this pos is going to its 3 yr low of .75 area. What junk!

[nonsequetor]

Q4 will be interesting

[nonsequetor]

WOW!! Nice EOD catapult!!

[nonsequetor]

Another week... another wait...

ZZZZZZZZZZZZZZZZZZZZZZ

[MattSav]

Good looking week... Hope everyone is enjoying this move upwards... I know we are waiting on 4th quarter for real numbers but wondering if the sentiment here is good enough to through another 10k on shares lol

[nonsequetor]

YES!

[MattSav]

So should we be excited that they are doing Financials on a Tuesday?

[MattSav]

So is the corporate presentation today or what I can't open the damn thing

[nonsequetor]

https://www.sec.gov/Archives/edgar/data/0001401914/000149315222019342/ex3-1.htm

[MattSav]

Anyone find out how the vote went?

[kruy]

You do realize that all the upfront payments and tiered royalties have to be split with the labs that actually invented and produce these products. DARE is only the middleman. These details are all spelled out in the last SEC annual filing.
The best thing that could happen for us shareholders is that some big company that needs a pipeline will buy out this company and its entire complicated business model. Give me $5 a share and I'm happy. Reality wise, I think we could only get $3-$4 because they would need to come to agreements with all the labs that actually engineered all of the products. Either way, I'd be happy with any buyout because the business model as is could take a long time for DARE to break even or show a profit after splitting royalties with all parties involved.

[nonsequetor]

$$$$ Coming in from the Gates!
https://ih.advfn.com/stock-market/NASDAQ/dare-bioscience-DARE/stock-news/88547783/current-report-filing-8-k

[nonsequetor]

This DARE stock will drive a sane man crazy!

[harry crumb]

Employee stock incentive plan goes into effect with dare Bod approval. Always good news to have a employee purchase plan for company stock

[MattSav]

So im new to this stock... What are the opinions of the stock not getting its approval to increase shares?

[nonsequetor]

Just a few more days...

[nonsequetor]

CLINICAL TRIALS RESULTS JUST POSTED
https://www.clinicaltrials.gov/ct2/show/results/NCT03598088?view=results

[nonsequetor]

[nonsequetor]

Main catalyst coming soon: FDA approval of NDE for Ovaprene, non hormonal birth control product. The company already in partnership with Bayer and NIH on this.
$1B
market. NDE approval will trigger the start of a pivotal Ph3 trial this year. Hopefully, their second FDA-approved product by next year. The trial will only cost them $5, and they get a bonus check from Bayer
$20M
on start.

Other pipeline catalysts soon:
1)Xaciato marketing/sales/revenue by Q4 or earlier.
2) VVA-1 Ph2 data: Q3
3) Sildenafil Ph2 data: Q3

[nonsequetor]

From Someone Very Smart
Path to 4.5B MC.

+Initial 10m payment from Organon for Xaciato commencements.
+Sales growth from XACIATO creating a close to breakeven or better cash flow within 2 years. Share price is a reflection of expected future value. Strong sales = big upside potential.
+ Ovaprene IDE acceptance. Bayer thinks that Ovaprene could be it's next billion dollar BC option.
+ $20m Ovaprene payment from Bayer. Would show confidence, solidify balance sheet and give investors more confidence.
+Eventual Ovaprene Approval. $300m+ in incentives + double digit royalties.
+ Sildenafil. Highly likely to be a billion+ annual sales drug with no competition if approved. It alone could boost us to a multi-billion dollar market cap.
+ LARC
+ Deeper pipeline

3 - 5 year horizon. Pretty straightforward path to multi-billion territory."

Long shots - Sale of any of the top 4 candidates. BO of company outright. $6-10 overnight.

[nonsequetor]

Steady and sure... up DARE goes...